Biogen chief brings in $11.3M in 2011 pay

Biogen Idec ($BIIB) CEO George Scangos (pictured) has restructured the company, streamlined R&D and benefited from drug development begun before his term began. Now, with Biogen share price at an all-time high, Scangos has reaped $11.3 million in compensation for 2011. Report